Patients with perampullary carcinoma and a high-risk profile to develop postoperative pancreatic fistulas
Conditions
Brief summary
Duration between surgery and the date of the decision "fit for adjuvant treatment" (postoperative day X)
Detailed description
Duration between surgery and the actual start of adjuvant therapy, Perioperative morbidity and mortality, Number and type of adverse events and serious adverse events, Quality of life (post-surgery, EORTC QLQ-C30/Pan26), Metabolic outcome, Oncological long term course (60 months)
Interventions
DRUGAutologous pancreatic islets
Sponsors
Technische Universitat Dresden
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Duration between surgery and the date of the decision "fit for adjuvant treatment" (postoperative day X) | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration between surgery and the actual start of adjuvant therapy, Perioperative morbidity and mortality, Number and type of adverse events and serious adverse events, Quality of life (post-surgery, EORTC QLQ-C30/Pan26), Metabolic outcome, Oncological long term course (60 months) | — |
Countries
Germany
Outcome results
None listed